Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 0 | 0 | 0 |
Full Text Views | 235 | 235 | 42 |
PDF Downloads | 205 | 205 | 33 |
The rise in COVID-19 cases in late 2021 posed a grave threat to the public health system and the economy of Jamaica. A key pillar of controlling COVID-19 includes rapid diagnosis of SARS-CoV-2 infected individuals and their contacts. Hence, we evaluated the feasibility and acceptability of weekly deployment of antigen rapid diagnostic tests (Ag-RDTs) by conducting three 6-week studies within high-risk populations in Jamaica. We enrolled 1) 287 study participants (≥18 years) from low-income communities (Study A), 2) 262 healthcare workers (Study B), and 3) 88 students (14–17 years) (Study C). Conducting these independent studies was challenging. Willingness to participate was generally low with fear of phlebotomy (42%), discomfort associated with nasal swab (39%), and lack of parental consent (35%) being the most common reasons students gave (Study C) for lack of participation. Furthermore, only 57%, 66%, and 88% of participants concluded their final study visit in studies A to C, respectively. Participants’ commitment and external factors, such as severe weather and outbreaks of violence affected follow-up. Overall, a total of six participants (<1%) tested COVID-19 Ag-RDT positive during all three studies, thus the number of infections detected were too low to draw any conclusions relating to the efficacy of the testing approach. Antibodies against SARS-CoV-2 were detected in most study participants (78–94%), but vaccination rates differed significantly between communities. Understanding these differences in vaccination rates is important because, given the low participation and follow-up rate, mass vaccination may present a more suitable public health intervention than regular testing.
Financial support: This project was supported through FIND through a grant received from the
Disclosure: The study was approved by the Mona Campus Research Ethics Committee (approval number ECP 116, 21/22).
Current contact information: David Walcott, Melanie Dawkins, Samantha Johnson, Kristen Collins, Vanessa Bailey-Higgins, and Shaquielle Dias, Novamed, Kingston, Jamaica, E-mails: david@novamedhealth.com, melaniedawkins.cydja@gmail.com, samantha@novamed.inc, kristencollins@gmail.com, nessa_b1890@hotmail.com, and shaqtdias@gmail.com. Chika Ozongwu, Carl Bruce, Alison Nicholson, Camille-Ann Thoms Rodriguez, Jerome Patrick Walker, John Lindo, and Tresana Pearson, University Hospital of the West Indies, Kingston, Jamaica, E-mails: chikaozongwu@gmail.com, carbruce03@gmail.com, mopsy@cheerful.com, camille.thoms-rodrigues@uwimona.edu.jm, jerome.walker@uwimona.edu.jm, john.lindo@uwimona.edu.jm, and tresanapearson@gmail.com. Pallavi Dani, FIND, Geneva, Switzerland, E-mail: pallavi.dani@finddx.org. Anne Hoppe, Elizabeth Glaser Pediatric AIDS Foundation, Geneva, Switzerland, E-mail: ahoppe@pedaids.org.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 0 | 0 | 0 |
Full Text Views | 235 | 235 | 42 |
PDF Downloads | 205 | 205 | 33 |